| Patents for C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972) |
|---|
| 04/16/2009 | WO2006047507A3 Phosphonate substituted kinase inhibitors |
| 04/15/2009 | EP2046786A2 Polymorphic forms of ziprasidone sulfates |
| 04/09/2009 | US20090093524 Compounds and methods for modulating fxr |
| 04/08/2009 | EP2045246A1 Derivatives of benzo[d] isothiazoles as histone deacetylase inhibitors |
| 04/08/2009 | EP2044041A2 Isothiazolidines useful in the treatment of ocular hypertensive conditions |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/02/2009 | US20090085006 Activators for oligonucleotide synthesis |
| 04/01/2009 | CN101397280A Method for preparing reactive isothiazolinone antibacterial finishing agent |
| 03/31/2009 | US7511149 Using ruthenium tetraoxide and alkali metal permanganate |
| 03/31/2009 | US7511072 7-amido-isoindolyl compounds and methods of its use |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/25/2009 | EP2039690A1 3,4-dihalogenoisothiazole derivative and agent for controlling agricultural or horticultural plant disease |
| 03/18/2009 | EP2035398A2 Immobilized 1,2-benzisothiazolin-3-one |
| 03/18/2009 | EP0963984B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics |
| 03/17/2009 | US7504424 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 03/12/2009 | US20090069317 Insecticidal Methods Using 3-Amino-1,2-Benzisothiazole Derivatives |
| 03/10/2009 | US7501505 1,1-Dioxo-1,2-dihydro-1 lambda 6-benzo[d]isothiazol-3-one will promote condensation of a nucleoside phosphoramidite and nucleoside monomer or a nascent oligonucleotide; genetic disorder diagnosis; gene expression inhibitors; treating cytomegalo virus; industrial scale |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/05/2009 | US20090062355 Pharmaceutical Product |
| 03/04/2009 | CN101379036A Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 03/03/2009 | US7498351 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 03/03/2009 | US7498349 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 02/12/2009 | US20090043094 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 02/11/2009 | CN101365690A Biphenyl derivatives as modulators of voltage gated ion channels |
| 02/10/2009 | US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
| 02/05/2009 | WO2009017813A1 O-desmethyl venlafaxine saccharinate |
| 02/05/2009 | US20090036420 Benzamide derivatives and their use for treating cns disorders |
| 02/03/2009 | US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease |
| 01/29/2009 | WO2009013122A2 Azo dyes |
| 01/29/2009 | US20090030000 Antiviral agents |
| 01/28/2009 | EP2018872A1 Pharmaceutical product |
| 01/28/2009 | CN101353330A Production method of 1,2- benzisothiazole-3-ketone |
| 01/22/2009 | WO2009012312A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 01/22/2009 | WO2009011276A1 Zinc salt of isothiazolone compound, method of reducing stimulus of isothiazolone compound, antibacterial/antifungal method employing zinc salt of isothiazolone compound, and antibacterial/antifungal composition |
| 01/22/2009 | US20090023924 Processes for the preparation of isothiazole derivatives |
| 01/22/2009 | US20090023789 N-[(5Z)-4-butyl-2-tert-butylisothiazol-5(2H)-ylidene]-5-chloro-2-methoxybenzamide; CB2 receptors ligand; antiinflammatory, analgesic agent; autoimmune diseases; neuroprotectants |
| 01/22/2009 | US20090023779 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 01/22/2009 | CA2690619A1 Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases |
| 01/21/2009 | EP2017268A1 1,2-benzisothiazole derivative, and agricultural or horticultural plant disease-controlling agent |
| 01/21/2009 | CN101348470A Synthetic method of alkyl isothiazole ketone hydrochlorate |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/15/2009 | US20090018056 Heteroarylcarbamoylbenzene derivatives |
| 01/14/2009 | EP2013184A1 Sulfonamide compounds useful as edg receptor modulators |
| 01/14/2009 | EP1258484B1 Novel isoxazole and thiazole compounds and use thereof as drugs |
| 01/01/2009 | US20090005353 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome |
| 12/31/2008 | EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives |
| 12/31/2008 | EP2007717A1 Novel sulfonamide compounds |
| 12/30/2008 | US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 12/30/2008 | US7470792 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same |
| 12/25/2008 | US20080319017 Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor Modulators |
| 12/25/2008 | US20080318976 Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists |
| 12/24/2008 | WO2008157802A1 3-hydroxyisothiazole-4-carboxamidine derivatives as chk2 inhibitors |
| 12/24/2008 | EP2006286A2 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i |
| 12/24/2008 | EP2006284A1 Dicyclooctane derivates, preparation processes and medical uses thereof |
| 12/24/2008 | EP2004601A1 Novel dipeptidyl peptidase iv inhibitors and processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2008 | EP2003975A1 3-amino-1,2-benzisothiazole compounds for combating animal pest |
| 12/23/2008 | US7468439 Alkylene bridged sultam compounds useful as modulators of nuclear hormone receptor function |
| 12/23/2008 | US7468378 Substituted quinoline compounds |
| 12/18/2008 | WO2008154484A1 Ire-1a inhibitors |
| 12/18/2008 | CA2690913A1 Ire-1alpha inhibitors |
| 12/11/2008 | WO2008130953A3 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 12/11/2008 | US20080306125 nuclear receptor modulators such as 6-{4-[3-(2,6-Dichloro-phenyl)-5-isopropyl-isoxazol-4-ylmethoxy]-phenyl}-1-isopropyl-1H-indole-3-carboxylic acid, used for treating dyslipidemia, atherosclerosis, diabetes, raising plasma high density lipoproteins, lowering low density lipoproteins and triglycerides |
| 12/10/2008 | CN101318146A Application of dehydroabietylamine thiourea catalyst in synthesizing chiral compound with high-antipodism both-hand control |
| 12/04/2008 | US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 12/02/2008 | US7459580 Process for trans-4-amino-1-cyclohexanecarboxilic acid derivatives |
| 12/02/2008 | US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides |
| 11/27/2008 | WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents |
| 11/27/2008 | CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents |
| 11/26/2008 | EP1802566B1 Hexafluoroisopropanol substituted ether derivatives |
| 11/20/2008 | WO2008090048A3 3-amino-1,2-benzisothiazole compounds for combating animal pest ii |
| 11/20/2008 | WO2007129019A8 Sulfonamide compounds useful as edg receptor modulators |
| 11/18/2008 | US7453000 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof |
| 11/13/2008 | WO2008136382A1 Bicyclic compound and pharmaceutical use thereof |
| 11/13/2008 | US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects |
| 11/13/2008 | CA2684703A1 Bicyclic compound and pharmaceutical use thereof |
| 11/12/2008 | CN100432049C Cycloalkene derivatives, process for producing the same and use |
| 11/11/2008 | US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones |
| 11/06/2008 | WO2007139645B1 Immobilized 1,2-benzisothiazolin-3-one |
| 11/05/2008 | CN101298441A Method for reclaiming 1,2- benzoisothiazoline-3-ketone from mother liquor |
| 11/05/2008 | CN100430411C Activators for oligonucleotide synthesis |
| 10/30/2008 | WO2008130953A2 2-imin0is0thiaz0le derivatives as cannabinoid receptor ligands |
| 10/30/2008 | WO2008103185A3 Substituted carboxamides as group i metabotropic receptor antagonists |
| 10/30/2008 | CA2684003A1 Novel compounds as cannabinoid receptor ligands |
| 10/29/2008 | EP1984340A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 10/28/2008 | US7442240 Alkoxylpropylisothiazolinone and preparation method and use thereof |
| 10/23/2008 | WO2008126772A1 Therapeutic agent for hypertension |
| 10/23/2008 | WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors |
| 10/22/2008 | EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 10/16/2008 | WO2008123469A1 Six-membered amide compound and use thereof |
| 10/16/2008 | US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread |
| 10/16/2008 | US20080255122 Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/09/2008 | US20080249315 Having an acylsulfonamide amine-reactive groups; crosslinker for amine containing material such as gel and hydrgels |
| 10/08/2008 | CN101282970A Chemical process |
| 10/07/2008 | US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance |
| 10/07/2008 | CA2426009C Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles |
| 10/01/2008 | EP1372655B1 Cathepsin cysteine protease inhibitors |
| 10/01/2008 | CN101277939A Acyclic ikur inhibitors |